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Globally, cestode zoonoses cause serious public health problems, particularly in Asia. Among all neglected zoonotic
diseases, cestode zoonoses account for over 75% of global disability adjusted life years (DALYs) lost. An
international symposium on cestode zoonoses research and control was held in Shanghai, China between 28th and
30th October 2012 in order to establish joint efforts to study and research effective approaches to control these
zoonoses. It brought together 96 scientists from the Asian region and beyond to exchange ideas, report on
progress, make a gap analysis, and distill prioritizing settings with a focus on the Asian region. Key objectives of this
international symposium were to agree on solutions to accelerate progress towards decreasing transmission, and
human mortality and morbidity caused by the three major cestode zoonoses (cystic echinococcosis, alveolar
echinococcosis, and cysticercosis); to critically assess the potential to control these diseases; to establish a research
and validation agenda on existing and new approaches; and to report on novel tools for the study and control of
cestode zoonoses.
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Cestode zoonoses are emerging, re-emerging or spread-
ing worldwide, and are classed as neglected infectious
diseases or neglected tropical diseases (NTDs), and
neglected zoonotic diseases (NZDs) [1,2]. Among all
NZDs, Asia currently has the greatest burden of cystic
echinococcosis (CE) and alveolar echinococcosis (AE) in
humans with these accounting for over 75% of global
disability adjusted life years (DALYs) lost, and primarily
occurring in west and north China and the Central
Asian Republics [3-7]. Many joint efforts have been
made to reduce or even eliminate the transmission of
this group of zoonoses [8]. Over the last decade or so,
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reproduction in any medium, provided the ortwo important symposia on cestode zoonoses were or-
ganized in China (in 2000 and 2006), and one work-
shop in Japan in 2011 [9-11]. In 2006, the Chinese
Government launched a national control program for
echinococcosis, the largest such program in the world
[12,13]. However in Asia, many challenges still need to
be overcome to effectively deal with these diseases.
Challenges include the lack of adequate investment,
and insufficient understanding of disease transmission
at the community level and its molecular epidemiology.
Applications of modern tools are required to obtain
evidence about pathogenic aspects, nature of genotypes
or isolates, as well as specific confirmation/diagnosis of
the diseases themselves. Further understanding the
epidemiology and the transmission ecology at different
scales is also required. Furthermore, we should identify
research gaps and optimize strategies for control
or even elimination of cestode zoonoses in specified
region(s).
To respond to the increased requirement for strength-
ening international collaborations on research and con-
trol of cestode zoonoses with a focus on the Asian
region, an international symposium was jointly proposed
and co-organized in Shanghai by the National Institute
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ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ease Control and Prevention, and the Asahikawa Med-
ical University in Japan. A total of 96 scientists attended
and engaged in topics as diverse as treatment, diagnosis,
molecular biology, epidemiology, transmission ecology,
public health and health policy, and progress in research
and control of cestode zoonoses in Asia, including gap
analysis and priority settings.
Methods
This international conference focused on the control of
cestode zoonoses, and involved 96 participants from 11
countries, the Chinese Ministry of Health (MOH), the
World Health Organization (WHO) Regional Office and
non-government organizations (NGOs). During the two-
day symposium, five keynote speakers introduced the
current global situation of cestode zoonoses from vari-
ous perspectives. Thirteen speakers addressed the Asian
status of cestode zoonoses, and recent achievements on
biological, spatial, molecular and diagnostic aspects.
Twenty-two participants in four parallel sessions shared
their experiences and progress on epidemiology, ecology,
biology, immunology, molecular taxonomy and phyl-
ogeny, control strategy, diagnosis, vaccine research, clin-
ical treatment, and public policy related to cestode
zoonoses control (see Tables 1 and 2).
In the roundtable interaction, participants joined discus-
sions about how to make a systematic assessment related
to: a) the current endemic/epidemic situation of cestode
zoonoses with a focus on Asian countries; b) the current
national and international control strategies for cestode
zoonoses; c) effective approaches to implement intersectoral
efforts on survey and control of cestode zoonoses; d) im-
portance of epidemic surveillance networks and informa-
tion reporting systems; and e) opportunities, challenges,
feasibilities, sustainability and technique demand for ces-
tode zoonoses control.
During the symposium, the Delphi study was applied
for obtaining and understanding control bottleneck, re-
search and resource gaps, priority settings for research
and control, and other related problems from all domes-
tic and foreign participants [14]. Information was also
collected through information exchange, roundtable dis-
cussions, questionnaires, and quantitative analysis.
Progress on research and control for cestode zoonoses
The main contributions were in the following areas:
biology and eco-epidemiology, control and interventions,
molecular biology and diagnostics, gap analysis, and re-
search priorities.
Biology and epidemiology
Echinococcus According to recent surveys with a focus
on epidemiology in wildlife, prevalences of Echinococcusspp were reported as high as 61.7-64.5% (E. multilocularis
19.2-48.4%, E. shiquicus 26.7-29.0%, and mixed infection
of these two species 12.9-15.8%) in Tibetan fox popula-
tions [15,16]. A survey of Echinococcus spp in small mam-
mals on the Tibetan plateau was also conducted by
morphology and hemi-nested polymerase chain reaction
(PCR) with a prevalence of 7.8%, in which 44 of 45
samples were identified by the hemi-nested PCR as infec-
tions of E. multilocularis (97.8%) and one considered as
E. granulosus in Microtus fuscus [16]. Three morphologic-
ally different “species” observed at various stages were
reported to be distributed sympatrically in the Hulunbeier
pasture of Inner Mongolia, China, and was referred to as
E. multilocularis, E. sibiricensis and E. russicensis [17].
These studies greatly influenced further studies on
the genetic variation of Echinococcus species to be
conducted. However, some of the above-mentioned le-
sions have been confirmed to be an intra-species variation
of E. multilocularis by the most recent molecular studies
[18,19]. The controversial data suggest that it is essential
to carry out molecular identifications even further.
From continental to regional scales, human AE spatial
distribution appears to be highly aggregated and forms
discrete patches of endemicity within which hotspots of
much larger prevalences may occur. Using regional
spatial models helps to explain why transmission of E.
multilocularis is more intense in distinct ecological sys-
tems with various intermediate host communities, land-
scape, and climates in continental Asia [20-25]. The
dissolution of the Soviet Union was presented in the
symposium, showing that such an event caused great so-
cioeconomic changes that pushed people back into trad-
itional small-holding livestock husbandry which resulted
in both human CE and AE emerging or re-emerging
[5,6]. Due to the long asymptomatic development of the
parasite in humans, monitoring dog and/or fox popula-
tions is recommended as a better way to anticipate risks
for human exposure [26].
The analysis of spatial patterns of human and animal
case distribution can provide information on transmis-
sion processes of E. multilocularis, and thus might help
in the design of evidence-based monitoring and control
programs. Some recent investigations in the Asian con-
tinent were introduced in the symposium with the per-
spective of featuring distinct types of transmission
ecosystems based on intermediate host communities.
These can serve as a reference for further in-depth re-
search and help when considering surveillance systems
are being considered [23,27,28].
Taenia Regarding human taeniasis, results from
village-based studies in Tibetan communities of south-
west China demonstrated that the three human Taenia
species were co-endemic in farming areas, where
Table 2 The participants-affiliated institutions and their major research fields on taeniasis/cysticercosis
Institutions Major research fields References
Epidemiology Diagnosis Control and treatment Taxonomy
Asahikawa Med. Univ., Japan ☆ ☆ ☆ ☆ Ito A, 2003, 2006; Sako Y, 2009;
Yanagida T, 2010; Knapp J, 2011;
Nakao M, 2010; Nkouawa A, 2011.
Inst. of Parasit Dis., Sichuan CDC, China. ☆ Li TY, 2006, 2012.
National Inst. of Infect. Dis., Japan. ☆ Yamasaki H, 2013
Tottori Univ., Japan. ☆ Yamane K, 2012
Universidade Federal do Tocantins, Brazil. ☆ ☆ Sato MO, 2011
Univ. of Ngaoundere, Cameroon. ☆ Assana E, 2013
Note: The institutions are listed in alphabetical order and the references shown in the table are those that have been published.
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☆ ☆ ☆ ☆ Ito A, 2003, 2006, 2007; Xiao N, 2005,
2006; Knapp J, 2011; Mamuti W,




☆ Jiang W, 2012
Fudan Univ., China. ☆ Cui SJ, 2013
Hokkaido Univ.,
Japan.
☆ Dang ZS, 2012
Inst. of Parasit Dis,
Sichuan CDC, China.









☆ ☆ ☆ ☆ Wang LY, 2010; Liu CS, 2012; Wang Y,
2012; Xiao N, 2012.
Ningxia Med Univ.,
China.
☆ Yang YR, 2010
Universita di Pavia,
Italy.
☆ ☆ Brunetti E, 2004, 2010.
Univ. of Franche-
Comte, France.
☆ ☆ Giraudoux P, 2006, 2013; Pleydell DR,
2008.
Univ. of Salford, UK. ☆ Craig PS, 1991, 2000, 2006.
Univ. of Ulm,
Germany.
☆ ☆ Kern P, 2006
Univ. of Zurich,
Switzerland.
☆ Budke CM, 2004; Torgerson PR, 2006.
Xiamen Univ.,
China.
☆ ☆ Tang CT, 2006
Xinjiang Med.
Univ., China
☆ ☆ ☆ Bart JM, 2006; Abstract book of the
symposium, 2012.
Note: The institutions are listed in alphabetical order and the references shown in the table are those that have been published.
*Epidemiology contains disease burden research.
**In this table, omics consist of genomics, proteomics, transcriptomics, immunomics, etc..
*** Ecology includes animal epidemiology and identification of Echinococcus spp.
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(see Figure 1). Overall infection rate of taeniasis ranged
from 3-20% and seroprevalence of human cysticercosis
varied from 4-7% [29,30]. Some participants reported
the situation of taeniasis and cysticercosis in humans
and livestock in Asian countries, including an infection
survey which surprisingly showed that T. asiatica was
reported in 25 confirmed patients in Japan and linked
to the consumption of raw pig liver. However the ori-
gins of the taeniasis cluster could not be identified due
to a lack of geographical variations in the DNA markers
used [31].Figure 1 Taenia worms collected from a Tibetan agricultural village. K
from villagers.Control programs and integrated interventions
Echinococcosis Dogs have been recognized as the main
definitive hosts of E. granulosus (G1 sensu stricto)
in China and Central Asian Countries, and an important
domestic host of E. multilocularis. However, dog-centered
hydatid control interventions in rural pastoral communi-
ties are more difficult where CE and AE are co-endemic.
Many questions need answering such as the natural
re-infection rate in dogs for E. granulosus and E.
multilocularis, and the potential for dogs to maintain fox-
independent transmission of E. multilocularis [23,32]. In
this symposium, a one-year observation of seasonal re-ey: A: the worms expelled from a Tibetan girl. B: the worms collected
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Ganzi Tibetan Autonomous Prefecture, Sichuan Province,
China, revealing that spring and winter were the seasons
when re-infection was most likely to occur. Therefore, a
simplified dog deworming scheme, which was both cost-
effective and easily implemented, was proposed, in which
dog deworming with praziquantel (PZQ) was done mainly
in spring and winter [16].
Regarding activities aimed at raising awareness and
thus being instrumental in the disease’s control, it was
reported that a series of target-specific health educa-
tional materials were developed and applied for
community-based health education in the Qinghai-Tibet
plateau region with the overall aim of raising compliance
of Tibetan populations in echinococcosis endemic areas.
The materials printed consisted of a Tibetan calendar, a
notebook, a pencil bag, a teaching wall chart, a school
health textbook, a picture storybook, an animated car-
toon and a picture poster, and these were each targeted
for the different population needs of religious staff, local
government staff, students, and residents (see Figure 2).
The assessments for field use showed that these mate-
rials are useful in improving knowledge and behavior,
and acceptable by most Tibetan populations [33]. Train-
ing on diagnosis and treatment of echinococcosis also
showed a significant effect on local capacity building in
increasing the expertise at prefecture and county levels
in Tibetan regions.
Combined use of PZQ and albendazole (ABZ) in a CE
patient with multi-infected organs was reported, in
which the treatment was a cyclic combination therapy of
ABZ at 400 mg twice a day for five days, with PZQ at
800 mg a day for two more days of the week. The regi-
ment was repeated for 10 courses with a two-week
interval between courses. The results indicated that
both lung and liver cysts reduced in size and no side ef-
fects were observed, suggesting a potential additional
option for medical therapy [16]. To explore the possi-
bility to increase the bioavailability and cysticidal effi-
cacy of benzimidazoles, the bioavailability of drug-oily
solvent suspensions was evaluated. The results demon-
strated that the solubility and bioavailability of benz-
imidazoles in oils may increase to various degrees, and
their effects against hydatid cysts were also significantly
enhanced [34].
To meet reasonable medical service needs of remote
populations from different ethnic groups, a form of
teleconsultation was introduced as a novel approach for
remote clinical consultation, multi-disciplinary discus-
sion, surgery demonstration, and theoretical training.
Echinococcosis patients in remote areas could thus, in
theory, benefit from optimal implementation of local
treatment, correct referral, as well as high-quality, inex-
pensive and convenient medical consultation.Taeniasis/cysticercosis To control Taenia solium taeni-
asis, and consequently the risk of cysticercosis, the use-
fulness of traditional oral anthelmintic (consisting of
pumpkin seeds combined with areca nut extract) was
assessed in a community-based treatment for human
taeniasis. The results showed that the traditional Chin-
ese herbal treatment was highly effective in expelling in-
tact tapeworms in over 89% of taeniasis cases [29].
Other efforts to reduce transmission have also been
made by improving sanitary practices, especially safe dis-
posal of human feces and improved management of pigs.
In general, economic development in rural areas of de-
veloping countries is also likely to lead to a decline in T.
solium transmission in the future. Theoretically at least,
T. solium cysticercosis is capable of being eradicated en-
tirely. More recently, treatment of pigs with oxfendazole
and development of an extremely effective vaccine for
pigs (Tsol18) have been shown to have great potential in
reducing transmission at the community level [35], par-
ticularly in the latter, leading to the complete elimination
of disease transmission in vaccinated pigs in a field trial
in Cameroon [36]. However, many practical issues re-
main as challenges – including scale and cost – to the
implementation of these measures.
Molecular biology and diagnostics
Echinococcus Based on the need for reappraisal of the
species within the genus Echinococcus variants, geno-
types or strains, some of which are poorly or not infect-
ive to humans, a molecular taxonomic discussion sought
to reinforce the necessity to revise the taxonomic status
and to recognize nine species in the genus Echinococcus
i.e. E. granulosus, E. equinus, E. ortleppi, E. canadensis,
E. felidis, E. multilocularis, E. shiquicus, E. vogeli, and E.
oligarthrus [37-39]. Accumulated molecular evidence
provided by participants to the symposium emphasized
that, based on the host specificity of E. canadensis, the
previous genotypes of E. granulosus i.e. G6, G7, G8, and
G10 should now be regarded as E. canadensis [39]. In
Russia, E. canadensis (G6) was detected in a human infec-
tion case. E. granulosus was not only found in humans
and sheep, but also reported in a cat, while three geno-
types of E. multilocularis – the Mongolian, Asian, and
North-American types – were confirmed from a variety of
hosts including the Asian type in human cases [40,41].
Recombinant Em18 from E. multilocularis was
recommended as a good candidate for the serological
detection of almost all active AE cases (PNM classifica-
tion) [42] and was therefore highly useful for monitoring
the progression of AE. Recombinant antigen B8/1 from
E. granulosus was reported to be another good candidate
to detect the majority of active CE cases i.e. CE2, CE3a,
and CE3b (WHO-IWGE US classification) [43,44]. Rapid
immunochromatographic kits for serodiagnosis of
Figure 2 Designed health educational materials to raise compliance to echinococcosis control activities. Key: A: a Tibetan calendar; B: a
teaching wall chart; C: one page of a picture storybook.
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been developed for field use [45,46]. Also, a genus spe-
cific excretory-secretory protein that is overexpressed
at the adult stage of Echinococcus, EgAgB8/3, was
assessed for coproantigen detection in an ELISA test
for dog infection, revealing 85% sensitivity and 95.7%
specificity [47,48]. Recently, screening and identifica-
tion of new antigens by immunoproteomic analysis has
been conducted by a Chinese group, and 21 antigenic
proteins were identified including 12 new ones [49]. Aproteomic analysis of the adult stage of E. granulosus in
dogs was performed and a series of proteins associated
with survival, development, movement and modulation
were identified, and thus improved the repertoire of
candidate proteins for vaccination, immunodiagnosis,
and drug development [50]. Vaccine development
against experimental rodent alveolar echinococcosis
using a novel tetraspanin molecule was introduced in
the symposium [51]. To overcome the difficulty in
fox sampling, a new quantitative PCR to detect
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for large-scale as well as fine spatial resolution studies,
was presented [16]. Some research reported the study
of dynamic changes of cytokines in a mice model
infected with E. granulosus and showed that Th1 is the
major response in the early stage of infection, while
Th2 is the major response between the 8th and 16th
week after the infection [16].
Taenia Molecular phylogeography has highlighted the
evolution and dispersal history of zoonotic taeniid
cestodes. Based on the phylogeographic analyses for T.
solium using mitochondrial gene markers, it was
reported that there are two genetically distinct geo-
graphic subgroups: Asian and African-American [52,53].
Although there has long been a debate as to the specific
status of the cestode Taenia asiatica, molecular analysis
strongly indicates that T. saginata and T. asiatica were
separated into two independent species. On the other
hand, hybridization between these two human Taenia
species seems to be an ongoing event in the co-endemic
areas [54-56].
A review of recent advances in immunodiagnosis of cys-
ticercosis and some latest research progress were reported
including development of an immunochromatographic
test, and a simple and reliable purification method of gly-
coproteins for immunodiagnosis of human and pig cysti-
cercosis [57]. A reliable serodiagnostic test for human and
porcine cysticercosis has been established by a Japanese
group [11]. Combination of surveillance tools such as
specific serology, copro-detection and molecular epidemi-
ology, in conjunction with GIS and spatial analysis,
will assist in understanding the transmission dynamics
of T. solium between humans and animals, and in opti-
mizing baseline studies and intervention follow-ups and
monitoring.
Gap analysis
It is recognized that substantial gaps exist in the con-
trol and research of cestode zoonoses globally, particu-
larly in Asia. Key challenges include capacity building;
governance and quality control of research; identi-
fying knowledge gaps of burden estimation of the
diseases; development of socioeconomic indicators; re-
source mobilization; need to develop inter-programmatic,
intersectoral prevention and control strategies; and
linking research, program and policy for evidence-
based decision making.
Echinococcosis
Epidemiology, ecology and surveillance of E. granulosus
and CE, and potential for control programs, should in-
clude country-wide mapping of cestode zoonoses, and
the reporting of medical and veterinary data in auniform way. As well as that, basic livestock information
is required, for example: 1) Do cysts accumulate? 2)
Does use of repeated low dose ABZ for G1 nematode in-
fections have any effect on hydatid cysts?
It is necessary to further improve copro-ELISA tests, to
assess loop-mediated isothermal amplification (LAMP)
and copro-DNA detection, and to run multi-center
assessments of copro- and serological tests and their
standardization. Up until now, low-cost serological tests
for CE and livestock serology remain problematic. In
control and prevention of CE, there is a need to: evaluate
integrated use of EG95 vaccine and PZQ trials over a
five-year period to measure dog re-infection rates in dif-
ferent endemic zones pre- and during PZQ dosing re-
gimes, to minimize dog dosing frequencies that can be
used in a given transmission zone/system, to develop
setting-specific health education materials, and to further
undertake research on experimental dog vaccines. There
is also a growing interest in, and importance applied to,
systematically analyzing and evaluating the four-five year
progress data from dog and human indices for interim
assessment of the Chinese National Control Program of
Echinococcosis. In the program, mainly comprehensive
control measures are taken including dog management
and monthly deworming with PZQ, health education,
livestock management and immunization, case chemo-
therapy with ABZ, and surgical treatment.
In epidemiology, ecology and surveillance of AE,
the gaps are: mapping distribution; development of
landscape risk maps; age structure of small mammal
host populations for infection studies; reliable rodent
taxonomy for host species in Eurasia; assessment of the
DNA profiles in unusual Inner Mongolian E. multilocularis
isolates (species, genotypes, haplotypes); copro-tests for
parasite and host identification; evaluation of uncertainty in
diagnostic tests; reliability of serological tests for early AE
lesion detection in humans; re-infection rates in dogs; and
potential for dogs to maintain a synanthropic cycle without
significant fox populations. In control and prevention of
AE, the gaps which need to be investigated are centered
around: the role of domestic dogs being important in the
transmission of E. multilocularis in co-endemic areas under
hydatid control programs, the problem of stray dogs in
some areas, the potential for sustainable dog-small mam-
mal transmission, and the behavior of the red fox, the Ti-
betan fox and the corsac fox in the wild versus among
human communities.
Taeniasis/cysticercosis
Gaps in research on epidemiology, ecology, and surveil-
lance of taeniasis/cysticercosis need to be focused on
distribution maps for countries and accurate hospital
data; DALYs calculation for cysticercosis burden, and
proportion of epilepsy due to neurocysticercosis in
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sis data; the minimum effort required to reduce transmis-
sion to Ro < 1; transmission dynamics basic parameters for
T. solium; multi-center assessment of current serological
tests (Glycoprotein antigen, Circulating antigen) for hu-
man and pig cysticercosis; specificity in relation to T.
hydatigena; effective DNA detection by LAMP for field
use; and increased studies on epidemiology and transmis-
sion of T. solium in Asia. In control and prevention of tae-
niasis/cysticercosis, many factors need to be addressed
such as the availability of copro-ELISA for mass screening,
drugs for taeniasis mass drug administration (PZQ, more
restricted niclosamide or others), and integrated use of
Tsol18 vaccine and oxfendazole in pig populations
through pilot studies.
Research priorities
Cestode zoonoses, as one group of neglected tropical
diseases and neglected zoonotic diseases, mainly affect
the poorest sectors of the populations and poor livestock
keepers living in rural, often remote and disadvantaged
regions of developing countries, and contribute to ser-
ious public health problems in the Asian region. China
is one of the countries with the highest disease burden
of cestode zoonoses in the world, where human CE, AE,
and cysticercosis are endemic, and even co-endemic, lo-
cally. Human AE is known to be common in certain
rural agricultural and pastoral communities. Though
globally rare, about 91% of new AE cases globally occur-
ring each year are detected in China with about 380 en-
demic counties and about 86 million people at risk,
particularly in the Qinghai-Tibet plateau region and
Western Sichuan. Cestode zoonoses are, however,
neglected with little attention from policy-makers, lack
of priority within health strategies, and inadequate base-
line research.
In this symposium, research priorities were recognized.
They included the need to understand the relationship be-
tween infectious diseases and poverty, and contribute to
priority settings for plans to control those diseases by the
introduction of the “one health, one world” concept with
trans-disciplinary approaches. It is essential to apply mod-
ern tools to obtain scientific evidence on parasite species,
strains or isolates, as well as on the confirmation of the
diseases themselves, and to further understand epidemi-
ology and transmission ecology. The priorities were also
raised to promote optimal opportunities and strategy for
control and international collaborations with emphasis on
those features, and to improve diagnosis, treatment and
control. In addition, estimations of burden of diseases, de-
velopment of socioeconomic indicators, developing a
country-specific control strategy and implementing it,
evidence-based interventions, and the use of identified
best practices were all identified as important.Conclusion
Cestode zoonoses, as a neglected group of potentially
life-threatening infectious diseases, pose an important
public health challenge globally, particularly in Asian
countries. They have substantial socioeconomic impacts
as they impact groups beyond those directly affected,
disproportionately impact on resource-poor communi-
ties in rural or remote areas, and furthermore, impact
the health and productivity of livestock.
At this international conference, it was agreed that the
following initiatives and recommendations should be
undertaken:
 Making a critical assessment on the potential for
control of cestode zoonoses focusing on the regions
where the populations are at higher risks;
 Establishing a research and validation agenda on
new approaches, and novel tools for study and
control of the diseases;
 Developing a work-plan of action targeting
interventions; and
 Exploiting more resources, favorable public policy,
and control options and strategies against cestode
zoonoses.
The WHO has recently listed echinococcosis as both
a NZD [1] and a NTD [2] to prioritize attention for
control strategies leading up to 2018. Cysticercosis/tae-
niasis has also been placed on the list of the six major
helminth diseases of humans for the control and elim-
ination based on a compelling research and develop-
ment agenda [58,59]. In 2012, the WHO published its
roadmap to set out targets for intensified control of
selected zoonoses and helminthiases. In January 2013,
the WHO published its second report which set mile-
stones for reaching the goals and targets outlined in the
roadmap expanding the concept of universal health
coverage [60,61].
In this symposium, the possible next steps to achieve
an integrated animal-human health approach have been
recommended. These include:
 Promoting the concept of “one health” by the
development of integrated “control packages” to deal
with health problems in people, livestock, and other
domestic and wild animals;
 Taking effective measures to raise the profile of the
NZDs both internationally and within affected
countries;
 Systematically collecting data on the incidence of
those zoonoses with support by studies to estimate
their dual burden on people and on livestock, to
quantify under-reporting, and to identify
communities and groups at risk; and
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effectively control these diseases, particularly in the
field of diagnostics.
It is high time to further understand these diseases
and fill the gaps on what needs to be done, as well as to
make joint efforts to control and research these diseases
with a focus on the priority areas identified in this inter-
national conference. In addition, it is easy to define the
research priorities, but translating these into operational
control methods remains a big challenge. This could not
be conducted effectively without a good health system
and by increasing the prioritization of these diseases.
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